Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/15/2882359/37149/en/PDS-Biotech-Provides-Business-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/09/2879304/37149/en/PDS-Biotech-VERSATILE-002-Phase-2-Clinical-Trial-Meets-Primary-Study-Endpoints-in-First-Line-Recurrent-Metastatic-HPV16-Positive-Head-and-Neck-Cancer.html
https://www.globenewswire.com/news-release/2024/05/09/2878726/37149/en/PDS-Biotech-to-Participate-in-Upcoming-May-2024-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/07/2876656/37149/en/PDS-Biotech-to-Announce-First-Quarter-2024-Financial-Results-on-May-15-2024.html
https://www.globenewswire.com/news-release/2024/05/03/2875080/37149/en/PDS-Biotechnology-Announces-Details-of-Virtual-KOL-Event.html
https://www.globenewswire.com/news-release/2024/04/23/2867593/37149/en/PDS-Biotech-to-Host-Key-Opinion-Leader-Event-to-Discuss-Positive-Updated-Data-from-Phase-2-VERSATILE-002-Clinical-Trial-with-Versamune-HPV-in-Combination-with-KEYTRUDA-in-Recurrent.html
https://www.globenewswire.com/news-release/2024/03/27/2853060/37149/en/PDS-Biotech-Announces-Clinical-Strategy-Update-and-Reports-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/13/2845346/37149/en/PDS-Biotech-Announces-Publication-of-Preclinical-Research-and-Grant-of-U-S-Composition-of-Matter-Patent-for-Infectimune.html
https://www.globenewswire.com//news-release/2024/01/22/2813504/37149/en/PDS-Biotech-Announces-Retirement-of-Lauren-V-Wood-M-D-and-Appointment-of-Kirk-V-Shepard-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com//news-release/2024/01/16/2809798/37149/en/PDS-Biotech-to-Participate-at-B-Riley-Securities-4th-Annual-Oncology-Conference.html